EuropaBio - Revision history

Claire Robinson: /* GM in the developing world */

2010-11-05T00:44:08Z

GM in the developing world

Claire Robinson: /* GM in the developing world */

2010-11-05T00:43:20Z

GM in the developing world

Claire Robinson: /* The killing fields */

2010-11-05T00:42:28Z

The killing fields

John Ashmore at 14:06, 4 September 2009

2009-09-04T14:06:59Z

Claire Robinson at 21:15, 10 March 2009

2009-03-10T21:15:05Z

Mira Purska at 16:47, 29 November 2007

2007-11-29T16:47:03Z

Mira Purska at 15:45, 29 November 2007

2007-11-29T15:45:37Z

Mira Purska at 19:07, 27 November 2007

2007-11-27T19:07:10Z

Mira Purska at 14:53, 27 November 2007

2007-11-27T14:53:11Z

Mira Purska at 18:16, 26 November 2007

2007-11-26T18:16:36Z

@@ Line 16: / Line 16: @@
 ==GM in the developing world==
-But while its focus is on Europe, EuropaBio has sought to use the Third World both as a means of promoting GM crops and as a means of undermining opposition. In January 2003, Bernd halling on behalf of EuropaBio brought ten 'representatives' from developing countries to deliver their favorable perspective on biotech to the EU. The 'team' included [[Luke Mumba]] from Zambia, [[TJ Buthelezi]] from South Africa, [[S Reddy]] from the [[Federation of Farmers Association in India]], [[Joceleyn Webster]] - executive director of [[AfricaBio]] and [[Margaret Karembu]] of the [[ISAAA]]. Among the varuious activities in Brussels a few members of the team were selected by EuropaBio to lobby select Members of the European Parliament.  The team also visited Rome to lobby the FAO and attend a seminar arranged by the US embassy to the Holy See. While the main focus was on Brussels and Rome, 3 of the team fitted in a trip to London to give a press conference for the UK lobby group Cropgen on the 'need for biotechnology for their continent.'  (See the [http://www.absfafrica.org Summary Report] on the trip).
+But while its focus is on Europe, EuropaBio has sought to use the Third World both as a means of promoting GM crops and as a means of undermining opposition. In January 2003, Bernd halling on behalf of EuropaBio brought ten 'representatives' from developing countries to deliver their favorable perspective on biotech to the EU. The 'team' included [[Luke Mumba]] from Zambia, [[TJ Buthelezi]] from South Africa, [[S Reddy]] from the [[Federation of Farmers Association in India]], [[Jocelyn Webster]] - executive director of [[AfricaBio]] and [[Margaret Karembu]] of the [[ISAAA]]. Among the varuious activities in Brussels a few members of the team were selected by EuropaBio to lobby select Members of the European Parliament.  The team also visited Rome to lobby the FAO and attend a seminar arranged by the US embassy to the Holy See. While the main focus was on Brussels and Rome, 3 of the team fitted in a trip to London to give a press conference for the UK lobby group Cropgen on the 'need for biotechnology for their continent.'  (See the [http://www.absfafrica.org Summary Report] on the trip).
 One of the main focuses of the press conference in London was the food aid crisis in Zambia, and the magazine New Scientist subsequently ran an article which was strongly critical in tone of the British Medical Association, on the basis of claims made at the press conference by the Zambian, Luke Mumba, that the BMA's caution over GM had had a big influence on the zambian government's rejection of GM contaminated food aid.

@@ Line 16: / Line 16: @@
 ==GM in the developing world==
-But while its focus is on Europe, EuropaBio has sought to use the Third World both as a means of promoting GM crops and as a means of undermining opposition. In January 2003, Bernd halling on behalf of EuropaBio brought ten 'representatives' from developing countries to deliver their favorable perspective on biotech to the EU. The 'team' included [[Luke Mumba]] from Zambia, [[TJ Buthelezi]] from South Africa, [[S Reddy]] from the [[Federation of Farmers Association in India]], [[Joceleyn Webster]] - executive director of [[AfricaBio]] and [[Margaret Karembu]] of the [[ISAAA]]. Among the varuious activities in Brussels a few members of the team were selected by EuropaBio to lobby select Members of the European Parliament.  The team also visited Rome to lobby the FAO and attend a seminar arranged by the US embassy to the Holy See. While the main focus was on Brussels and Rome, 3 of the team fitted in a trip to London to give a press conference for the UK lobby group Cropgen on the 'need for biotechnology for their continent.'  (See the [http://www.absfafrica.org Summary Report]  on the trip)
+But while its focus is on Europe, EuropaBio has sought to use the Third World both as a means of promoting GM crops and as a means of undermining opposition. In January 2003, Bernd halling on behalf of EuropaBio brought ten 'representatives' from developing countries to deliver their favorable perspective on biotech to the EU. The 'team' included [[Luke Mumba]] from Zambia, [[TJ Buthelezi]] from South Africa, [[S Reddy]] from the [[Federation of Farmers Association in India]], [[Joceleyn Webster]] - executive director of [[AfricaBio]] and [[Margaret Karembu]] of the [[ISAAA]]. Among the varuious activities in Brussels a few members of the team were selected by EuropaBio to lobby select Members of the European Parliament.  The team also visited Rome to lobby the FAO and attend a seminar arranged by the US embassy to the Holy See. While the main focus was on Brussels and Rome, 3 of the team fitted in a trip to London to give a press conference for the UK lobby group Cropgen on the 'need for biotechnology for their continent.'  (See the [http://www.absfafrica.org Summary Report] on the trip).
 One of the main focuses of the press conference in London was the food aid crisis in Zambia, and the magazine New Scientist subsequently ran an article which was strongly critical in tone of the British Medical Association, on the basis of claims made at the press conference by the Zambian, Luke Mumba, that the BMA's caution over GM had had a big influence on the zambian government's rejection of GM contaminated food aid.

@@ Line 8: / Line 8: @@
 ==The killing fields==
-A leaked 1997 report on communication methods produced for EuropaBio by the PR firm Burston Marsteller warned, 'All the research evidence confirms that the perception of the profit motive fatally undermines industry&#39;s credibility on these questions'. ([http://www.spinprofiles.org/images/6/6a/Europabio.doc Communications Programmes for EuropaBio], [[Burson Marsteller]], January 1997). The report encouraged EuropaBio to influence politicians and regulators in order that they in turn could win public trust regarding the safety of GM crops.
+A leaked 1997 report on communication methods produced for EuropaBio by the PR firm Burston Marsteller warned:
 The primary focus of EuropaBio's lobbying is the European Union, where it seeks to shape legislation in a way that suits its members' interests. To this end it provides 'a steady flow of information about biotechnology to the European Parliament, the European Commission and the Council of Ministers.' Through its member associations, EuropaBio also 'fosters a standing dialogue with policy makers and stakeholders at a national level'.

← Older revision		Revision as of 14:06, 4 September 2009
Line 1:		Line 1:
		+	{{Template:Foodspin badge}}
		+
	[http://www.europabio.org EuropaBio], the [[European Association for Bioindustries]], is 'the voice of the European biotech industry'. It is made up of some 600 [http://www.europabio.org/eu_corporate.htm companies], ranging from the largest biotechnology companies in Europe (including the European offices of US companies like Monsanto) to [http://www.europabio.org/eu_nba.htm national biotech federations] representing small and medium-sized enterprises. <ref>http://www.europabio.org/eu_board.htm</ref>		[http://www.europabio.org EuropaBio], the [[European Association for Bioindustries]], is 'the voice of the European biotech industry'. It is made up of some 600 [http://www.europabio.org/eu_corporate.htm companies], ranging from the largest biotechnology companies in Europe (including the European offices of US companies like Monsanto) to [http://www.europabio.org/eu_nba.htm national biotech federations] representing small and medium-sized enterprises. <ref>http://www.europabio.org/eu_board.htm</ref>

@@ Line 27: / Line 27: @@
 ==Notes==
 <references/>
-[[Category:Food Industry lobby groups]]
+[[Category:Food Industry lobby groups]][[Category:GM]][[Category:Biotech Industry]][[Category:GM Lobby Groups]]

@@ Line 1: / Line 1: @@
 [http://www.europabio.org EuropaBio], the [[European Association for Bioindustries]], is 'the voice of the European biotech industry'. It is made up of some 600 [http://www.europabio.org/eu_corporate.htm companies], ranging from the largest biotechnology companies in Europe (including the European offices of US companies like Monsanto) to [http://www.europabio.org/eu_nba.htm national biotech federations] representing small and medium-sized enterprises. <ref>http://www.europabio.org/eu_board.htm</ref>
-Members include all of the major European multinationals with significant biotechnology interests, such as Bayer, [[Novartis]], [[Monsanto]] Europe, [[Nestle]], Novo [[Nordisk]], [[Rhene-Poulenc]], and [[Unilever]].
+Members include all of the major European multinationals with significant biotechnology interests, such as [[Bayer]], [[Novartis]], [[Monsanto]] Europe, [[Nestle]], Novo [[Nordisk]], [[Rhene-Poulenc]], and [[Unilever]], [[Assobiotec]], [[Degussa]], [[GlaxoSmithKline]].
 EuropaBio is based in Brussels. The director of EuropaBio's Plant Biotechnology Unit (PBU) is Simon Barber. EuropaBio's Public Affairs manager is [[Bernd Halling]]. The chairman of Europabio board is [[Steen Riisgaard]]. Among the vice-chairs is [[Aisling Burnand]], [[Bernward Garthoff]], [[Ian Hudson]], [[Andrea Rappagliosi]].<ref>http://www.europabio.org/eu_board.htm</ref>

@@ Line 3: / Line 3: @@
 Members include all of the major European multinationals with significant biotechnology interests, such as Bayer, [[Novartis]], [[Monsanto]] Europe, [[Nestle]], Novo [[Nordisk]], [[Rhene-Poulenc]], and [[Unilever]].
-EuropaBio is based in Brussels. The director of EuropaBio's Plant Biotechnology Unit (PBU) is Simon Barber. EuropaBio's Public Affairs manager is [[Bernd Halling]]. The chairman of Europabio board is [[Steen Riisgaard]]. Among the vice-chairs is [[Aisling Burnand]], [[Dr. Bernward Garthoff]].<ref>http://www.europabio.org/eu_board.htm</ref>
+EuropaBio is based in Brussels. The director of EuropaBio's Plant Biotechnology Unit (PBU) is Simon Barber. EuropaBio's Public Affairs manager is [[Bernd Halling]]. The chairman of Europabio board is [[Steen Riisgaard]]. Among the vice-chairs is [[Aisling Burnand]], [[Bernward Garthoff]], [[Ian Hudson]].<ref>http://www.europabio.org/eu_board.htm</ref>
 ==The killing fields==